11.49 Total Revenues 1,765.11 1,947.37 Selling & Administrative Expenses 115.05 120.12 Finance Costs 23.44 20.98 Net Profit 10.37 9.12 Earnings per share (Baht) 0.026 0.023 The company will explain the
Subsidiaries’ Financial Statement as of June 30, 2019 MDX Public Company Limited (“MDX”) would like to explain major factors that affect Q2/2019 consolidated operating results as follows: ▪ There is no land-sale
Subsidiaries Financial Statement as of June 30, 2018. MDX Public Company Limited (“MDX”) would like to explain major factors that affect Q2/2018 consolidated operating results as follows: ▪ MDX has THB 53.55
Subsidiaries Financial Statement as of September 30, 2018. MDX Public Company Limited would like to explain major factors that make Q3/2018 operating results shown in MDX Public Co., Ltd and its subsidiaries
and was treated according to the standard procedures with the opportunity to explain and present supporting documents and evidence. His translator also explained the statement to him before he signed to
and was treated according to the standard procedures with the opportunity to explain and present supporting documents and evidence. His translator also explained the statement to him before he signed to
revised ( 23 record(s) found) Order Date Company Name Reviewed Financial Statement Details 12/04/2018 ENERGY EARTH PUBLIC COMPANY LIMITED SEC extends deadline for EARTH to clarify the existence and the fair
revised ( 23 record(s) found) Order Date Company Name Reviewed Financial Statement Details 12/04/2018 ENERGY EARTH PUBLIC COMPANY LIMITED SEC extends deadline for EARTH to clarify the existence and the fair
revised ( 23 record(s) found) Order Date Company Name Reviewed Financial Statement Details 12/04/2018 ENERGY EARTH PUBLIC COMPANY LIMITED SEC extends deadline for EARTH to clarify the existence and the fair
Building Confidence in the Capital Market No. 115/2017 SEC notifies PACE to clarify the fair value measurement of its investment Bangkok, 16 November 2017 – The SEC has notified Pace Development